Copyright
©The Author(s) 2020.
World J Gastroenterol. Sep 14, 2020; 26(34): 5130-5145
Published online Sep 14, 2020. doi: 10.3748/wjg.v26.i34.5130
Published online Sep 14, 2020. doi: 10.3748/wjg.v26.i34.5130
Figure 1 Flow-sheet of the 632 patients participated in the study and liver-related events (development of cirrhosis, liver decompensation, hepatocellular carcinoma development) observed during follow up.
- Citation: Gatselis NK, Tornai T, Shums Z, Zachou K, Saitis A, Gabeta S, Albesa R, Norman GL, Papp M, Dalekos GN. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients. World J Gastroenterol 2020; 26(34): 5130-5145
- URL: https://www.wjgnet.com/1007-9327/full/v26/i34/5130.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i34.5130